1. 1- Rambaree K, Mousavi F, Ahmadi F. Sports participation and drug use among young people in Mauritius. Int J Adolesc Youth. 2018;23(2):188-97. [ Link] [ DOI:10.1080/02673843.2017.1325756] 2. Pasharavesh L, Ramandi M, Khoshboo S, Rezaee M, Rezvani S, Abbasi MR, et al. Prevalence of doping agents' abuse and male bodybuilders' knowledge about their side effects in Kermanshah gymnasiums (2004). J Kermanshah Univ Med Sci. 2008;11(4):e80462. [Persian] [ Link] 3. Bates G, Begley E, Tod D, Jones L, Leavey C, McVeigh J. A systematic review investigating the behaviour change strategies in interventions to prevent misuse of anabolic steroids. J health psychol. 2017:1359105317737607. [ Link] [ DOI:10.1177/1359105317737607] 4. Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart. 2004;90(5):496-501. [ Link] [ DOI:10.1136/hrt.2003.015719] [ PMID] [ PMCID] 5. Halabchi F. Doping in athletes. Hakim. 2007;10(1):1-12. [ Link] 6. Malek M, Ghorbani R, Ghanaei M. Survey of the frequency percentage of doping drugs among the male-body building athletes and rate of knowledge to side effects. Koomesh. 2005;6(2):123-30. [Persian] [ Link] 7. Jalilian F, Allahverdipour H, Moeini B, Moghimbeigi A. Effectiveness of anabolic steroid preventative intervention among gym users: Applying theory of planned behavior. Health Promot Perspect. 2011;1(1):32-40. [ Link] [ PMID] [ PMCID] 8. Fayyazi Bordbar MR, Abdollahian E, Samadi R, Dolatabadi H. Frequency of use, awareness, and attitudes toward side effects of anabolic–androgenic steroids consumption among male medical students in Iran. Subst Use Misuse. 2014;49(13):1751-8. [ Link] [ DOI:10.3109/10826084.2014.880175] [ PMID] 9. Aljuboury NH. Misuses and side effects of steroids derivatives. Int J Med Sci. 2019;2(1):1-4. [ Link] 10. Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32(2):534-42. [ Link] [ DOI:10.1177/0363546503262202] [ PMID] 11. Knapik JJ, Steelman RA, Hoedebecke SS, Austin KG, Farina EK, Lieberman HR. Prevalence of dietary supplement use by athletes: systematic review and meta-analysis. Sports Med. 2016;46(1):103-23. [ Link] [ DOI:10.1007/s40279-015-0387-7] [ PMID] [ PMCID] 12. Bijeh N, Dehbashi M, Saghi M. Studying the amount of prevalence awareness and complications of anabolic steroid among the male athletes in Mashhad City. J Pract Stud f Biosci Sport. 2014;2(4):78-89. [Persian] [ Link] 13. Arazi H, Hosseini R. The prevalence of anabolic-androgenic steroids abuse, knowledge and attitue of their side effects, and attitude toward them among the bodybuilding athletes in Rasht. J Guilan Univ Med Sci. 2012;20(80):34-41. [Persian] [ Link] 14. Nilsson S, Allebeck P, Marklund B, Baigi A, Fridlund B. Evaluation of a health promotion programme to prevent the misuse of androgenic anabolic steroids among Swedish adolescents. Health Promot Int. 2004;19(1):61-7. [ Link] [ DOI:10.1093/heapro/dah108] 15. Kargarfard M, Ghias M, Karimzadegan AR, Kashi A. Assumption of anabolic-androgenic steroids among Isfahan University students: prevalence, and awareness about their side effects. J Fundam Ment Health. 2007;8(32):73-80. [Persian] [ Link] 16. Slater G, Tan B, Teh KC. Dietary supplementation practices of Singaporean athletes. Int J Sport Nutr Exerc Metab. 2003;13(3):320-32. [ Link] [ DOI:10.1123/ijsnem.13.3.320] 17. Nakhaee MR, Pakravan F, Nakhaee N. Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran. Addict Health. 2013;5(3-4):77-82. [ Link] [ PMID] [ PMCID] 18. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids: a review for the clinician. Sports Med. 2002;32(5):285-96. [ Link] [ DOI:10.2165/00007256-200232050-00001] [ PMID] 19. Laure P. Epidemiologic approach of doping in sport. A review. J Sports Med Phys Fitness. 1997;37(3):218-24. [ Link] [ PMID] 20. Saati Asr MH, Bashirian S, HeidariMoghadam R, Barati M, Moeini B. Personal and psychosocial factors associated with anabolic-androgenic steroid use among Iranian male bodybuilders. J Subst Use. 2018;23(4):390-5. [ Link] [ DOI:10.1080/14659891.2018.1436600] 21. Rickert VI, Pawlak-Morello C, Sheppard V, Jay MS. Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr. 1992;31(12):723-6. [ Link] [ DOI:10.1177/000992289203101206] [ PMID] 22. Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008;371(9627):1872-82. [ Link] [ DOI:10.1016/S0140-6736(08)60801-6] 23. Kashi A, Kargarfard M, Moulavi H, Sarlak Z. Ergogenic substance in body building athletes: prevalence, cognitive and awareness of about their side effects. Q Olympic. 2006;14(2):73-86. [Persian] [ Link] 24. Shelley J, Moir HJ, Petroczi A. The use and misuse of testosterone in sport: the challenges and opportunities in doping control. In Nutrition and enhanced sports performance, muscle building, endurance, and strength. Bagchi D, Nair S, Sen C, editors. 2nd Edition. Cambridge: Academic Press; 2019. Pp.571-80. [ Link] [ DOI:10.1016/B978-0-12-813922-6.00048-5] 25. Nilsson S, Baigi A, Marklund B, Fridlund B. The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur J Public Health. 2001;11(2):195-7. [ Link] [ DOI:10.1093/eurpub/11.2.195] 26. Guimaraes-Ferreira L, Cholewa JM, Dantas WS, Murai I, Duncan MJ, Zanchi NE. Performance-enhancing drugs and sports supplements for resistance training. In Nutrition and enhanced sports performance, muscle building, endurance, and strength. Bagchi D, Nair S, Sen C, editors. 2nd Edition. Cambridge: Academic Press; 2019. Pp.31-47. [ Link] [ DOI:10.1016/B978-0-12-813922-6.00003-5] 27. Botvin GJ. Preventing drug abuse in schools: Social and competence enhancement approaches targeting individual-level etiologic factors. Addict Behav. 2000;25(6):887-97. [ Link] [ DOI:10.1016/S0306-4603(00)00119-2] 28. Dolan SL, Martin RA, Rohsenow DJ. Self-efficacy for cocaine abstinence: Pretreatment correlates and relationship to outcomes. Addict Behav. 2008;33(5):675-88. [ Link] [ DOI:10.1016/j.addbeh.2007.12.001] [ PMID] [ PMCID] 29. Tate SR, Wu J, McQuaid JR, Cummins K, Shriver C, Krenek M, et al. Comorbidity of substance dependence and depression: Role of life stress and self-efficacy in sustaining abstinence. Psychol Addict Behav. 2008;22(1):47-57. [ Link] [ DOI:10.1037/0893-164X.22.1.47] [ PMID] 30. Tavousi M, Heidarnia AR, Montazeri A, Taremian F, Akbari H, Haeri AS. Distinction between two control constructs: an application of the theory of planned behavior for substance abuse avoidance in adolescents. Q Horizon Med Sci. 2009;15(3):36-44. [Persian] [ Link]
|